Cargando…
Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease
Though Abl inhibitors are often successful therapies for the initial stages of chronic myelogenous leukemia (CML), refractory cases highlight the need for novel molecular insights. We demonstrate that mice deficient in the enzyme 12/15-lipoxygenase (12/15-LO) develop a myeloproliferative disorder (M...
Autores principales: | Middleton, Melissa Kristine, Zukas, Alicia Marie, Rubinstein, Tanya, Jacob, Michele, Zhu, Peijuan, Zhao, Liang, Blair, Ian, Puré, Ellen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118138/ https://www.ncbi.nlm.nih.gov/pubmed/17043146 http://dx.doi.org/10.1084/jem.20061444 |
Ejemplares similares
-
A novel role for 12/15-lipoxygenase in regulating autophagy
por: Morgan, Alwena H., et al.
Publicado: (2014) -
12/15-lipoxygenase inhibition attenuates neuroinflammation by suppressing inflammasomes
por: Cakir-Aktas, Canan, et al.
Publicado: (2023) -
Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure
por: Kayama, Yosuke, et al.
Publicado: (2009) -
12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance
por: Uderhardt, Stefan, et al.
Publicado: (2011) -
Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids
por: Gheorghe, Karina Roxana, et al.
Publicado: (2009)